John Maraganore
October 28, 2021
Alnylam Names Dr. Yvonne Greenstreet New CEO
Dr. Yvonne Greenstreet, currently Alnylam's President and COO, has been named Alnylam's new CEO effective year-end 2021, taking over from Dr. John Maraganore.
Read More ›
June 9, 2020
John Maraganore in "Biotechnology in the Time of COVID-19: Commentaries from the Front Lin ...
In a new e-book, dozens of biopharma industry leaders, including our CEO John Maraganore, share their perspectives from the industry's unique vantage point...
Read More ›
May 1, 2020
John Maraganore on the "I Am BIO" Podcast: Destroying COVID's Genome
Our CEO John Maraganore recently spoke with Biotechnology Innovation Organization (BIO) CEO and Chairman Jim Greenwood on the "I Am BIO" podcast.
Read More ›
April 11, 2019
Letter to the Editor: Federal Research is Important, but Companies Turn it Into Actual Tre ...
John Maraganore wrote a Letter to the Editor in The Washington Post about the importance of federal research...
Read More ›
January 3, 2019
John Maraganore Talks RNAi on Chemical & Engineering News Podcast
John Maraganore talks with Chemical & Engineering News' Lisa Jarvis and Ryan Cross on this episode of C&EN's Stereo Chemistry podcast.
Read More ›
December 11, 2018
John Maraganore Named to Bloomberg 50 List for 2018
Alnylam CEO John Maraganore has been named to the Bloomberg 50 list for 2018.
Read More ›
May 9, 2018
First Rounders: John Maraganore
Our CEO John Maraganore, Ph.D. recently chatted with the Nature Biotechnology Podcast about his path into science, through research and ultimately into biotech.
Read More ›
FOLLOW US
